首页> 外文期刊>American Journal of Transplantation >Cytomegalovirus Latency Promotes Cardiac Lymphoid Neogenesis and Accelerated Allograft Rejection in CMV Na?ve Recipients
【24h】

Cytomegalovirus Latency Promotes Cardiac Lymphoid Neogenesis and Accelerated Allograft Rejection in CMV Na?ve Recipients

机译:巨细胞病毒潜伏期促进CMV初次接受者的心脏淋巴新生和加速同种异体移植的排斥反应。

获取原文
获取原文并翻译 | 示例
           

摘要

Human cytomegalovirus (HCMV) infection is associated with the acceleration of transplant vascular sclerosis (TVS) and chronic allograft rejection (CR). HCMV-negative recipients of latently HCMV infected donor grafts are at highest risk for developing CMV disease. Using a rat heart transplant CR model, we have previously shown that acute rat CMV (RCMV) infection following transplantation significantly accelerates both TVS and CR. Here, we report that RCMV-na?ve recipients of heart allografts from latently RCMV-infected donors undergo acceleration of CR with similar kinetics as acutely infected recipients. In contrast to acutely infected recipients, treatment of recipients of latently infected donor hearts with ganciclovir did not prevent CR or TVS. We observed the formation of tertiary lymphoid structures (TLOs) containing macrophages and T cells in latently infected hearts prior to transplantation but not in uninfected rats. Moreover, pathway analysis of gene expression data from allografts from latently infected donors indicated an early and sustained production of TLO-associated genes compared to allografts from uninfected donors. We conclude that RCMV-induced TLO formation and alteration of donor tissue T cell profiles prior to transplantation in part mediate the ganciclovir-insensitive rejection of latently infected donor allografts transplanted into na?ve recipients by providing a scaffold for immune activation.
机译:人类巨细胞病毒(HCMV)感染与移植血管硬化(TVS)和慢性同种异体移植排斥(CR)的加速有关。 HCMV潜伏感染的供体移植物的HCMV阴性受体患上CMV疾病的风险最高。使用大鼠心脏移植CR模型,我们先前已经表明,移植后急性大鼠CMV(RCMV)感染会显着加速TVS和CR。在这里,我们报告说,来自潜在RCMV感染的供体的RCMV初次接受心脏同种异体移植的人接受CR的加速,其动力学与急性感染的受者相似。与急性感染的接受者相反,用更昔洛韦治疗潜伏感染的供者心脏的接受者不能预防CR或TVS。我们观察到潜伏感染的心脏在移植前含有巨噬细胞和T细胞的三级淋巴样结构(TLO)的形成,但未感染的大鼠中没有。此外,来自潜在感染供体的同种异体移植物的基因表达数据的途径分析表明,与来自未感染供体的同种异体移植物相比,TLO相关基因的早期和持续产生。我们得出结论,在移植前,RCMV诱导的TLO形成和供体组织T细胞谱的改变部分通过提供用于免疫激活的支架来介导更昔洛韦不敏感的潜在感染供体同种异体移植患者的移植。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号